STOCK TITAN
  1. Home
  2. Sec-filings
  3. BFRIW
  4. [S-1] Biofrontera Inc. Warrants Files IPO Registration Statement

[S-1] Biofrontera Inc. Warrants Files IPO Registration Statement

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
S-1
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock BFRIW logo
Biofrontera

NASDAQ:BFRIW

BFRIW Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

BFRIW Latest News

Jun 30, 2025
Biofrontera Inc. Announces Major Restructuring of Relationship With Biofrontera AG Backed By $11 Million Investment
Jun 11, 2025
BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG
Jun 3, 2025
Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book
May 15, 2025
Biofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update
May 15, 2025
Biofrontera Inc. Announces New Patent Protection on Ameluz® until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris

BFRIW Latest SEC Filings

Jul 16, 2025
[8-K/A] Biofrontera Inc. Warrants Amends Material Event Report
Jul 11, 2025
[D] Biofrontera Inc. Warrants SEC Filing
Jul 9, 2025
[Form 3] Biofrontera Inc. Warrants Initial Statement of Beneficial Ownership
Jul 1, 2025
[8-K] Biofrontera Inc. Warrants Reports Material Event
Jun 30, 2025
[8-K] Biofrontera Inc. Warrants Reports Material Event

BFRIW Stock Data

1.49M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
WOBURN